Antimicrobial prescribing: meropenem with vaborbactam
National Institute of Health and Care Excellence ,
Key messages The content of this evidence review was up-to-date in November 2019.
Key messages The content of this evidence review was up-to-date in November 2019.
– The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in…
/PRNewswire/ -- Autorisation le 20 novembre 2018 par la Commission européenne du méropénème/vaborbactam pour un usage clinique…